Search Results Search Sort by RelevanceMost Recent In the Literature Feb 2016 Ethical Dilemmas in Liver Transplant Organ Allocation: Is it Time for a New Mathematical Model? Aaron Ahearn, MD, PhD Organ allocation models that maximize the collective benefit of an organ rely on subjective criteria and might have unintended practical consequences. AMA J Ethics. 2016;18(2):126-132. doi: 10.1001/journalofethics.2017.18.2.nlit1-1602. In the Literature Aug 2006 The Benefit and Burden of Ancillary Professionals in Dermatology Seemal R. Desai, MD Virtual Mentor. 2006;8(8):514-516. doi: 10.1001/virtualmentor.2006.8.8.jdsc1-0608. In the Literature Sep 2005 Does How We Ask for Organs Determine Whether People Decide to Donate? Kelly A. Carroll Virtual Mentor. 2005;7(9):595-599. doi: 10.1001/virtualmentor.2005.7.9.jdsc1-0509. In the Literature Aug 2003 Children as Live Kidney Donors for Siblings Catherine Kim Virtual Mentor. 2003;5(8):319-321. doi: 10.1001/virtualmentor.2003.5.8.jdsc1-0308. In the Literature Mar 2012 Living-Donor Grafts for Patients with Hepatocellular Carcinoma Mohamed Elhassan Akoad, MD Virtual Mentor. 2012;14(3):215-220. doi: 10.1001/virtualmentor.2012.14.3.jdsc1-1203. In the Literature Feb 2012 Barriers and Biases: Ethical Considerations for Providing Emergency Contraception to Adolescents in the Emergency Department Rebecca C. Thilo When adolescents seek emergency contraception in the emergency room, social judgment on the part of clinicians can hamper treatment. Virtual Mentor. 2012;14(2):121-125. doi: 10.1001/virtualmentor.2012.14.2.jdsc1-1202. In the Literature Aug 2013 Why Clinical Oncologists Should Talk about the Price of Cancer Drugs Nancy Berlinger, PhD The cost of lifesaving cancer drugs is a moral concern for oncologists. Virtual Mentor. 2013;15(8):677-680. doi: 10.1001/virtualmentor.2013.15.8.jdsc1-1308. In the Literature Feb 2010 Risks and Benefits of Innovative Off-Label Surgery Caitlin E. Weber Controversy associated with off-label application of drugs and devices has arisen as innovative treatments clash with responsible regulation. Virtual Mentor. 2010;12(2):97-101. doi: 10.1001/virtualmentor.2010.12.2.jdsc1-1002.
In the Literature Feb 2016 Ethical Dilemmas in Liver Transplant Organ Allocation: Is it Time for a New Mathematical Model? Aaron Ahearn, MD, PhD Organ allocation models that maximize the collective benefit of an organ rely on subjective criteria and might have unintended practical consequences. AMA J Ethics. 2016;18(2):126-132. doi: 10.1001/journalofethics.2017.18.2.nlit1-1602.
In the Literature Aug 2006 The Benefit and Burden of Ancillary Professionals in Dermatology Seemal R. Desai, MD Virtual Mentor. 2006;8(8):514-516. doi: 10.1001/virtualmentor.2006.8.8.jdsc1-0608.
In the Literature Sep 2005 Does How We Ask for Organs Determine Whether People Decide to Donate? Kelly A. Carroll Virtual Mentor. 2005;7(9):595-599. doi: 10.1001/virtualmentor.2005.7.9.jdsc1-0509.
In the Literature Aug 2003 Children as Live Kidney Donors for Siblings Catherine Kim Virtual Mentor. 2003;5(8):319-321. doi: 10.1001/virtualmentor.2003.5.8.jdsc1-0308.
In the Literature Mar 2012 Living-Donor Grafts for Patients with Hepatocellular Carcinoma Mohamed Elhassan Akoad, MD Virtual Mentor. 2012;14(3):215-220. doi: 10.1001/virtualmentor.2012.14.3.jdsc1-1203.
In the Literature Feb 2012 Barriers and Biases: Ethical Considerations for Providing Emergency Contraception to Adolescents in the Emergency Department Rebecca C. Thilo When adolescents seek emergency contraception in the emergency room, social judgment on the part of clinicians can hamper treatment. Virtual Mentor. 2012;14(2):121-125. doi: 10.1001/virtualmentor.2012.14.2.jdsc1-1202.
In the Literature Aug 2013 Why Clinical Oncologists Should Talk about the Price of Cancer Drugs Nancy Berlinger, PhD The cost of lifesaving cancer drugs is a moral concern for oncologists. Virtual Mentor. 2013;15(8):677-680. doi: 10.1001/virtualmentor.2013.15.8.jdsc1-1308.
In the Literature Feb 2010 Risks and Benefits of Innovative Off-Label Surgery Caitlin E. Weber Controversy associated with off-label application of drugs and devices has arisen as innovative treatments clash with responsible regulation. Virtual Mentor. 2010;12(2):97-101. doi: 10.1001/virtualmentor.2010.12.2.jdsc1-1002.